Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Bone Loss”

471 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 471 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Not applicableStudy completedNCT05421819
What this trial is testing

Design and Development of a Novel Food Supplement for Osteoporosis Based on Gut Microbiome Mechanisms

Who this might be right for
OsteopeniaPostmenopausal Osteopenia
National and Kapodistrian University of Athens 117
Early research (Phase 1)Study completedNCT01969656
What this trial is testing

Safety Study of an Oral Vitamin D Analog in Postmenopausal Women

Who this might be right for
Postmenopausal Osteoporosis, Multiple Sites
Deltanoid Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00088010
What this trial is testing

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 9,369
Not applicableStudy completedNCT06250283
What this trial is testing

Resveratrol for the Prevention of Bone Loss in Postmenopausal Women

Who this might be right for
Low Bone Mass
University of Delaware 52
Large-scale testing (Phase 3)Study completedNCT00310531
What this trial is testing

3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women

Who this might be right for
Osteopenia
Bayer 500
Large-scale testing (Phase 3)Study completedNCT00545779
What this trial is testing

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

Who this might be right for
Post-Menopausal Osteoporosis
Hoffmann-La Roche 677
Early research (Phase 1)Study completedNCT00902356
What this trial is testing

A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women

Who this might be right for
Osteopenia
Amgen 69
Testing effectiveness (Phase 2)Study completedNCT00532337
What this trial is testing

Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis

Who this might be right for
OsteoporosisOsteopenia
Ono Pharma USA Inc 285
Not applicableLooking for participantsNCT07616401
What this trial is testing

MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis

Who this might be right for
OsteoporosisMenopause
Istituto Auxologico Italiano 42
Early research (Phase 1)Study completedNCT00950950
What this trial is testing

Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass

Who this might be right for
Osteopenia
Amgen 24
Testing effectiveness (Phase 2)Study completedNCT00043186
What this trial is testing

Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Low Bone Mineral Density
Amgen 412
Large-scale testing (Phase 3)Study completedNCT04664959
What this trial is testing

Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Samsung Bioepis Co., Ltd. 457
Not applicableStudy completedNCT04653350
What this trial is testing

High Intensity Multi-Modal Exercise Training in Postmenopausal Women

Who this might be right for
Postmenopausal OsteoporosisPostmenopausal Osteopenia
Riphah International University 58
Not applicableLooking for participantsNCT06525688
What this trial is testing

New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis FractureOsteoporosis, Severe
National and Kapodistrian University of Athens 60
Large-scale testing (Phase 3)Study completedNCT00172081
What this trial is testing

TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Shire 2,532
Post-approval studies (Phase 4)Study completedNCT00453492
What this trial is testing

Risedronate Sodium in Post Menopausal Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 246
Not applicableStudy completedNCT02247011
What this trial is testing

A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal Women

Who this might be right for
Osteoporotic FracturesOsteoporosis, Postmenopausal
Peking Union Medical College Hospital 1,100
Not applicableStudy completedNCT06264401
What this trial is testing

Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Cairo University 60
Post-approval studies (Phase 4)Study completedNCT04609189
What this trial is testing

Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss

Who this might be right for
Osteoporosis, Postmenopausal
University of Alberta 97
Load More Results